middle.news
Visionflex Boosts ARR 114% Amid Revenue Dip, Eyes Q4 EBITDA Profit
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Visionflex Boosts ARR 114% Amid Revenue Dip, Eyes Q4 EBITDA Profit
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Annual Recurring Revenue (ARR) rose 8% quarter-on-quarter to $1.6 million
Q2 FY25 revenue declined 11% to $0.9 million, with 37% recurring software revenue
New contracts signed with Spark Health NZ, BUPA, and Indigenous Wellness Connect trial
Operating cash outflow improved to $0.5 million, aided by a $0.5 million government grant
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Visionflex (ASX:VFX)
OPEN ARTICLE